CLEVELAND, July 15, 2024 (GLOBE NEWSWIRE) -- Five abstracts featuring SPR Therapeutics’ SPRINT PNS System generated interest from leading pain physicians at the American Society of Pain & Neuroscience ...
CLEVELAND, Nov. 21, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting, including positive results for the ...
SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain Under Aetna’s updated medical policy, the SPRINT PNS System ...
Our SPRINT ® PNS System fulfills a critical unmet need for a drug-free, surgery-free option for millions who suffer from chronic pain. Backed by the largest body of clinical evidence in peripheral ...
CLEVELAND, Jan. 21, 2020 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, today announced publication of a prospective case series regarding its ...
CLEVELAND, May 17, 2023 (GLOBE NEWSWIRE) -- SPR ® Therapeutics announced the publication of a comprehensive real-world retrospective data analysis of over 6,100 patients demonstrating significant pain ...
Over the last six years, more than 20,000 patients have been implanted with the Sprint PNS system to manage acute or chronic pain, SPR Therapeutics Inc. reported. The 20,000th patient was treated for ...
CLEVELAND, May 04, 2023 (GLOBE NEWSWIRE) -- SelectHealth, a non-profit health plan with over one million members, has demonstrated leadership amid the opioid crisis by creating one of the first ...
CLEVELAND, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the North American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results